Journal of Microbiology and Antimicrobials Vol. 3(5), pp. 112-118, May 2011
Available online http://www.academicjournals.org/JMA
ISSN 2141-2308 ©2011 Academic Journals
Full Length Research Paper
Prevalence of β-lactamase-producing and
non-producing methicillin resistant Staphylococcus
aureus in clinical samples in Bangladesh
Md. Ekramul Haque1, Mohammad Shahriar1, Anika Haq1, Bernadette Charlotte Gomes1,
M. Mahboob Hossain1, Md. Abdur Razzak2 and Md. Abdul Mazid3*
1
Department of Pharmacy, The University of Asia Pacific, Dhanmondi, Dhaka-1209, Bangladesh.
2
Department of Microbiology, Primeasia University, Banani, Dhaka-1213, Bangladesh.
3
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Dhaka-1000, Bangladesh.
Accepted 29 March, 2011
Staphylococcus aureus has been reported to be a major cause of community and hospital acquired
infections. Indiscriminate use of antibiotics resulted in the development of multi-drug resistant
S. aureus throughout the world. Development of multi-drug resistant strains of S. aureus is increasingly
alarming in Bangladesh. We attempted to study the current prevalence of β-lactamase-producing and
non-producing methicillin-resistant S. aureus (MRSA) in clinical samples and to find out the correlation
of antimicrobial resistance pattern with their plasmid profiles. Twenty three clinical isolates of
S. aureus were evaluated during the study period (2009). The isolates were identified by conventional
methods. Antibiotic susceptibility of the isolates was performed by disk diffusion method. Plasmid
profiles were observed by agarose gel electrophoresis. In the present investigation, 43·48% isolates
were ensured methicillin resistant while the remaining 56·52% isolates were found to be methicillin
sensitive by disk diffusion method. β-lactamase test which was performed by acid formation method
showed that 50% of the MRSA isolates produced β-lactamase. Our studies of resistance pattern to
commonly prescribed antimicrobials showed that MRSA isolates were highly sensitive to vancomycin
(100%), fusidic acid (90%), chloramphenicol (80%), neomycin (80%), rifampin (80%), gentamycin (70%),
ceftriaxone (60%), cephalexin (60%), ciprofloxacin (60%), and cloxacillin (60%). Plasmid profiling of the
selected resistant isolates of Staphylococcus revealed clear and distinct bands of plasmid DNA. These
isolates showed severe resistance to amoxicillin (70%), co-trimoxazole (90%) and erythromycin (80%).
Key words: Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), resistance, βlactamase, Bangladesh.
INTRODUCTION
Staphylococcus aureus, a spherical aerobic grampositive, catalase positive, oxidase positive, non-motile, spore-forming coccus, is an opportunistic pathogen in
human and animal, and is one of the most frequent
sources of hospital- and community-acquired infections.
Generally, S. aureus is responsible for superficial
infections and toxic epidermal necrolysis, systemic
infections such as endocarditis inflammation of bone or
bone marrow, pneumonia and toxinoses such as food
*Corresponding author. E-mail: mazid_ma@hotmail.com. Tel:
+880-2-9677623. Fax: 880-2-8615583.
poisoning or toxic shock syndrome. However, among
gram-positive cocci, only β-lactamase of major clinical
significance is Staphylococcal β-lactamase, which rapidly
hydrolyses benzylpenicillin, ampicillin, cephalosporins,
and related antimicrobials (Foster, 1996; Francis et al.,
1997; Brumfit and Hamilton, 1989; Sampathukumar,
2007; Daini and Akano, 2009; Hotu et al., 2007).
Methicillin-resistant S. aureus (MRSA) is a special strain
of S. aureus that is resistant to the antibacterial activity of
methicillin and other related antibiotics of the penicillin
class. MRSA have acquired genes encoding antibiotic
resistance to all penicillins, including methicillin and other
narrow-spectrum
β-lactamase-resistant
penicillin
antibiotics (O'Brien et al., 1999; Maltezou and
Haque et al.
Giamarellou, 2006; Boyce, 1994; Chambers, 2001;
Maltezou and Giamarellou, 2006). Although, MRSA has
traditionally been seen as a hospital-associated infection,
community-acquired MRSA strains have appeared in
recent years, notably in the USA and Australia (Okuma et
al., 2002). Several new strains of MRSA have been found
showing antibiotic resistance even to vancomycin and
teicoplanin; these new evolutions of the MRSA bacteria
are
called
Vancomycin
Intermediate-resistant
Staphylococcus aureus (VISA) (Sieradzki and Tomasz,
1997; Schito, 2006). MRSA is relatively ubiquitous and
is the cause of many community, endemic and epidemic
nosocomial colonization and infections ( Hsueh et al.,
2005; Marples and Reith, 1996; Chambers, 2001).
Community-acquired MRSA infections in the absence of
identified risk factors have been reported. Many
outbreaks of infections due to MRSA have occurred and
it has now become endemic in several centers in the
world (Brumfit and Hamilton-Miller, 1989; Boyce, 1994;
O’Brien et al., 1999). The emergence of communityacquired MRSA that is capable of causing infections in
otherwise healthy people has also been reported (Diep et
al., 2008; Daini and Akano, 2009). Staphylococcal
antibiotic resistance has been associated with resistant
plasmids that have the ability to mediate the production of
drug inactivating enzymes such as β-lactamases
(Adeleke and Odelola, 1997) and other functions (King et
al., 2006; Diep, 2006). MRSA also differ in their
resistance to antibacterial agents and in the genetic
location of these resistance determinants. Studies have
shown that the genetic determinants for antibiotic
resistance reside on plasmids, chromosomal DNA, or on
transposable elements (Lyon and Skurray, 1987; Udo,
1993).
In Bangladesh, as reported previously, the frequency of
MRSA was alarming due to indiscriminate and
incomplete uses of antibiotics (Khan et al., 1991;
Rahman et al., 2002). In 1991, 62.61% MRSA was
reported in a situation when methicillin was not yet
introduced in Bangladesh market (Khan et al., 1991).
However, in 2002 47.2% MRSA was reported in an
investigation on clinical S. aureus isolates (Rahman et
al., 2002). Both of these prevalence rates of MRSA were
higher than the rate in some developed countries like
Austria 21.6%, Belgium 25.1%, Spain 30.3%, and France
33·6% (Herwaldt and Wenzel, 1996). Therefore, the
current situation of the susceptibility patterns of local
strains is essential for the judicious use of antibacterial
agents as well as to become aware of the MRSA in
hospitals and community arenas in Bangladesh. Based
on this previous study, we took further initiation to look
into the recent prevalence of MRSA isolates in clinical
samples collecting from two largest pathological centers
at Dhaka city of Bangladesh.
The patterns of antibiotic susceptibility of methicillinsensitive and -resistant isolates to the commonly used
antimicrobial
agents were studied. β-lactamase
113
production and plasmid profiles of these bacteria were
also investigated.
MATERIALS AND METHODS
MRSA isolates
Twenty three isolates of S. aureus were obtained from the two
largest pathological centers: Medinova Medical Services and
Popular Diagnostic Center in Dhaka City, Bangladesh during our
study in 2009. The isolates were identified as S. aureus by gross
and microscopic morphology, and by biochemical tests such as
coagulase test, catalase test and oxidase test following established
methods. All isolates were collected from patients in whom S.
aureus was the sole causative infectious agent. The staphylococcal
infection was ensured by clinical and para-clinical correlations.
Mixed specimens were obtained from pus, blood, cerebrospinal
fluid (CSF), urine, throat swab, umbilical swab, sputum, prostatic
semen, etc.
Antibiotic susceptibility test
The pattern of antibiotic sensitivity of S. aureus to 17 antimicrobials
was determined by disk diffusion method (National Committee for
Clinical Laboratory Standards, 1997). The antimicrobial disks were
sourced from the HiMedia Laboratories Ltd., Mumbai, India. All
tests were performed on Mueller-Hinton agar (Oxoid Ltd.
Basingstoke, Hampshire, England) and zones of inhibition were
measured after incubation at 37°C for 24 h. The zone diameters
measured around each disk were interpreted on the basis of
guidelines by the NCCLS 1985 (Bauer et al., 1966).
β-Lactamase test
β-Lactamase production was assayed by the acid-formation
method. A piece of Whatman No.1 filter paper (5×6) was briefly
placed in a sterile Petri dish. The bluish penicillin solution was
added drop wise to saturate the paper. Thick masses of bacterial
colonies of the test organism were transferred with a bacteriological
loop from the test culture to the filter paper and spread over an area
of 5 mm diameter. The paper was then incubated at 37°C for 30
min with the Petri dish covered. The paper was examined and
yellow zones formed by β-lactamase producing strains were noted.
Plasmid profile analyses
Plasmid was isolated by miniprep methods and analyzed by
agarose gel electrophoresis using 1.5% agarose gel.
RESULTS AND DISCUSSION
We have investigated the current prevalence and pattern
of MRSA isolates in clinical samples collected from two
renowned pathological centers in Dhaka city,
Bangladesh. S. aureus was also examined for the
relationship of antimicrobial resistance with plasmid
profiles.
114
J. Microbiol. Antimicrob.
Ceftriaxone
Cephalexin
Cephradine
Chloramphenicol
Ciprofloxacin
Cloxacilline
Co-trimoxazole
Erythromycin
Fusidic Acid
Gentamicin
Neomycin
Oxacillin
Penicillin G
Rifampin
Tetracycline
Vancomycin
Pus
P/S (24/M)
Rt. Eye
P/S
W/S (5/M)
Rt. eye (36/M)
Pus 887
P/S (58/M)
Urine C-13
Urine (35/F)
T/S (2/M)
CSF (22/M)
Urine C-40
Pus (70/M)
Sputum
Pus 472
Blood
Urine C-29
T/S C-54
Pus 787
U/S (15D/M)
18E
8E
Amoxycillin
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
Specimen
Sample No.
Table 1. In vitro sensitivity pattern of Staphylococcus aureus to different antimicrobials.
R
R
S
R
R
S
R
R
R
R
R
R
R
R
S
R
S
S
S
S
S
S
S
S
S
S
S
S
S
R
S
R
S
S
R
R
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
R
S
S
R
S
R
S
S
S
R
S
S
S
S
S
S
S
S
S
S
S
S
S
R
S
R
S
R
R
R
S
S
R
R
S
S
S
S
S
S
S
S
S
S
S
R
R
S
S
S
R
R
S
S
S
S
S
S
S
S
S
S
S
S
R
S
R
R
S
R
R
S
R
R
R
S
R
S
S
S
S
S
S
S
R
S
S
S
S
S
S
S
S
S
R
S
S
R
R
S
S
S
S
R
S
S
S
S
S
R
S
R
R
S
R
R
R
R
R
R
R
R
R
R
R
S
S
R
S
S
S
S
S
S
S
R
S
R
R
R
R
S
S
R
R
R
S
R
S
R
R
S
R
S
S
S
S
S
S
R
R
S
S
S
S
S
S
R
R
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
R
S
R
S
R
R
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
R
S
R
S
S
S
S
R
S
R
S
S
S
S
S
S
S
S
S
S
S
R
R
S
S
R
S
R
R
S
R
R
S
S
R
S
R
R
S
S
S
S
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
S
S
S
S
R
R
R
S
S
S
S
R
S
S
S
S
S
S
S
S
S
S
S
S
S
S
R
S
S
R
R
S
R
R
R
M
S
S
S
S
S
S
R
S
R
R
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
Observation of in vitro antibiotic sensitivity pattern
and β-lactamase pattern
In vitro sensitivity patterns of 23 S. aureus isolates to
different antimicrobials are shown in Table 1 and
sensitivities to these isolates to oxacillin / methicillin are
shown in Table 2 and β-lactamase production patterns of
same staphylococcal isolates are shown in Table 3.
In this investigation, among the 23 clinical isolates of S.
aureus, 43.48% isolates were classified as methicillinresistant and 56.52% isolates were found to be
methicillin-sensitive (MSSA) by disk diffusion method
using 1 g oxacillin disk. Most of the isolates, both
MRSA and MSSA were sensitive to ceftriaxone (82.60%),
cephalexin (82·60%), cephradine (82.60%), fusidic acid
(82·60%) and gentamycin (82.60%). Methicillin-resistant
isolates were resistant to all β-lactam antibiotics. Among
the isolates (both MRSA and MSSA), high percentage of
isolates were resistant to co-trimoxazole (65.21%),
erythromycin (56.52%) and amoxicillin (56.52%), but the
resistance were higher in case of MRSA isolates, and
90% were resistant to co-trimoxazole, 80% to
erythromycin, and 70% to amoxicillin. Virtually, all S.
aureus were susceptible to vancomycin. In this study, no
isolates have been found susceptible to penicillin G. On
the other hand, all the isolates were susceptible to
vancomycin. These findings are similar to the findings of
Supriya et al., 1999 [33]. But they observed less
percentage of MRSA (19·56%) which is much lower than
the present study.
Test for β-lactamase production revealed that 43.48%
isolates produced β-lactamase. The highest number of
isolates was from pus (Table 4) and 80% of these
produced β-lactamase. Of the isolates from pus samples,
40% isolates were resistant to oxacillin and both of them
have produced β-lactamase and the remaining 60%
isolates was sensitive to oxacillin of which, only 33.33%
isolates produced β-lactamase. The second highest
number of isolates was obtained from urine, of which all
the isolates were oxacillin- resistant and of the oxacillinresistant isolates, 25% produced β-lactamase while the
remaining isolates obtained from urine were found to be
Haque et al.
115
Ceftriaxone
Cephalexin
Cephradine
Chloramphenicol
Ciprofloxacin
Cloxacilline
Co-trimoxazole
Erythromycin
Fusidic Acid
Gentamicin
Neomycin
Oxacillin
Penicillin G
Rifampin
Tetracycline
Vancomycin
Rt. Eye
P/S
Pus 887
Urine C-13
Urine (35/F)
CSF (22/M)
Urine C-40
Pus 472
Urine C-29
T/S C-54
Amoxycillin
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
Specimen
Sample No.
Table 2. In vitro sensitivity pattern of MRSA to different antimicrobials
S
R
R
R
R
R
R
R
S
S
S
S
R
R
S
R
R
S
S
S
S
S
R
S
R
R
S
R
S
S
S
S
R
R
S
R
R
R
S
S
S
S
R
S
S
R
S
S
S
S
S
R
R
S
R
R
S
S
S
S
S
S
S
R
S
R
R
S
R
S
R
R
R
R
R
R
R
R
S
R
S
R
R
R
S
R
R
R
R
R
S
S
S
S
S
S
R
S
S
S
S
S
R
R
S
R
S
S
S
S
S
S
R
S
S
R
S
S
S
S
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
R
S
S
R
S
S
R
S
S
S
S
S
R
R
S
R
R
M
S
S
S
S
S
S
S
S
S
S
S
S
S
Table 3. Number of isolates from different specimens and their sensitivity to methicillin / oxacillin.
Specimen
Pus
Urine
Prostatic semen (P/S)
Right eye (Rt. eye)
Throat swab (T/S)
Wound swab (W/S)
Umbilical swab (U/S)
Cerebrospinal fluid (CSF)
Blood
Sputum
18E
8E
Total (%)
No. of isolate
5
4
3
2
2
1
1
1
1
1
1
1
23 (100)
oxacillin-sensitive and non-β-lactamase producing.
Among the isolates obtained from prostatic semen,
33·33% showed oxacillin resistance but did not produce
β-lactamase enzyme. Our data indicate that the isolates
obtained from pus and urine samples showed more
resistance to MRSA and also retained β-lactamase
production capacity.
Plasmid profile
resistance
observation
and
antimicrobial
To look into the plasmid profiles in MRSA, we selected 13
multi-drug resistant strains, isolated the plasmid DNA by
MSSA
3
2
1
1
1
1
MRSA
2
4
1
1
1
1
1
1
1
1
13 (56·52)
10 (43·48)
alkaline lysis miniprep method, and analyzed by agarose
gel electrophoresis (Figure 1). We also furthermore,
investigated the resistant patterns of these isolates using
17 different antimicrobials to correlate among these in
terms of plasmid presence and multi-drug resistance
(Table 5). From our data, we observed that the isolates
which showed resistance to more than three
antimicrobials possessed very distinct and clear plasmid
band(s) whereas, the isolates that showed resistance to
two or less of the tested antimicrobials possessed no
plasmid bands. Interestingly, isolate S5 (Pus 887)
showed resistance to 14 antimicrobials including penicillin
G, amoxycillin, gentamicin, ceftriaxone, cephalexin,
cephradine, co-trimoxazole, erythromycin, ciprofloxacin,
116
J. Microbiol. Antimicrob.
Table 4. In vitro β-lactamase production by S. aureus isolates.
Sam ple no.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
Specimen
Pus
P/S (2/M)
Rt. Eye
P/S
W/S (5/M)
Rt. Eye (36/M)
Pus 887
P/S (58/M)
Urine C – 13
Urine (35/F)
T/S (2/M)
CSF (22/M)
Urine C - 40
Pus (70/M)
Sputum
Pus 472
Blood
C-29 Urine
T/S C-54
Pus 787
U/S (15D/M)
18E
8E
β-Lactam ase production
(+)
(+)
(-)
(-)
(+)
(-)
(+)
(-)
(+)
(-)
(+)
(-)
(-)
(-)
(+)
(+)
(+)
(-)
(+)
(-)
(-)
(-)
(-)
(+) = β-Lactamase producer, (-) = non-β-lactamase producer, Rt. Eye = Right eye, P/S =
Prostatic Semen, T/S = Throat Swab, W/S = Wound Swab, U/S = Umbilical Swab, CSF =
Cerebrospinal Fluid, D = Day, M = Male, F = Female.
Figure 1. Gel electrophoresis result of 13 selected clinical isolates of S. aureus.
tetracycline, chloramphenicol, neomycin, fusidic acid and
oxacillin; and sensitivity to only 3 antimicrobials and
revealed light bands of plasmid DNA in the gel
electrophoresis analysis (Table 5, Figure 1). Isolate S7
(CSF, 22/M), showed resistance to 15 antimicrobials
including penicillin G, amoxycillin, co-trimoxazole,
erythromycin, ciprofloxacin, tetracycline, gentamicin,
ceftriaxone, cephalexin, cephradine, chloramphenicol,
cloxacillin, neomycin, rifampin and oxacillin and the
revealed clear and distinct band of plasmid DNA. On the
other hand, isolate S10 (Pus 787) showed resistance to
only two antimicrobials namely penicillin G and
tetracycline, and revealed no bands of plasmid DNA in
the gel electrophoresis. Whereas, isolate S12 (blood)
Haque et al.
117
Ceftriaxone
Cephalexin
Cephradine
Chloramphenicol
Ciprofloxacin
Cloxacilline
Co-trimoxazole
Erythromycin
Fusidic Acid
Gentamicin
Neomycin
Oxacillin
Penicillin G
Rifampin
Tetracycline
Vancomycin
Pus
Rt. Eye
P/S
W/S (5/M)
Pus 887
P/S (58/M)
CSF (22/M)
Pus (70/M)
Pus 472
Pus 787
U/S (15D/M)
Blood
T/S C-54
Amoxycillin
S1.
S2.
S3.
S4.
S5.
S6.
S7.
S8.
S9.
S10.
S11.
S12.
S13.
Specimen
Sample no.
Table 5. In vitro sensitivity pattern of 13 selected (plasmid-examined) clinical isolates of S. aureus to different antimicrobials.
R
S
R
R
R
R
R
R
R
S
S
S
S
S
S
S
S
R
S
R
S
S
S
S
S
S
S
S
S
S
R
S
R
S
R
S
S
S
S
S
S
S
S
R
S
R
S
R
S
S
R
S
S
S
S
S
R
S
R
S
S
S
S
S
S
S
S
R
R
R
R
R
R
S
S
S
S
S
S
S
S
S
S
S
R
S
S
S
S
S
S
R
R
R
S
R
R
R
R
R
S
S
S
R
S
S
R
S
R
R
R
R
R
S
R
S
R
S
S
S
R
S
S
S
R
S
S
S
S
S
S
S
S
S
R
S
R
S
S
S
S
S
S
S
S
S
R
R
S
R
R
S
S
S
S
S
S
R
R
S
R
S
R
S
R
S
S
S
R
R
R
R
R
R
R
R
R
R
R
R
R
R
S
S
S
R
R
S
R
S
S
S
S
S
S
S
S
R
S
R
R
R
S
S
R
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
S
showed resistance to two antimicrobials namely penicillin
G and cephradine and also revealed no bands of plasmid
DNA. The data as depicted in Figure 1 and Table 5 also
revealed that most of the plasmid containing isolates
showed resistance to co-trimoxazole, which predict the
presence of co-trimoxazole-resistant gene in the plasmid
because none of the co-trimoxazole sensitive isolates
showed plasmid bands.
In this study, investigation was carried out to know the
prevalence of multiple-drug resistant (MDR) genecarrying plasmids in the MRSAs but no vivid result was
found. However, multi-drug resistant isolates showed
more plasmid bands and all the isolates which did not
show any plasmid were sensitive to almost all the
antimicrobials. Our studies showed a 43·48% prevalence
of MRSA in the tested clinical samples which was almost
similar to that reported by Rahman et al. (2002). Such
high rates of MRSA have also been reported in India
(Anupurba et al., 2003; Vidhani et al., 2001). However,
Udaya et al. (1997) reported 20% MRSA and Mehta et al.
(1998) 32.8% MRSA in some regions of India. In Nepal,
Mulligan et al. (1993) reported 26.14% in its eastern part.
In summary, the prevalence of MRSA seems to be higher
in Bangladesh, India and Nepal as compared to other
parts of the world (Udo et al., 1993; Herwaldt and
Wenzel, 1996; Mulligan et al., 1993; Mansouri and
Khaleghi, 1997) except in Africa (Olukoya et al., 1995;
Adeleke and Odelola, 1997).
In this present study, most (70%) of the isolates which
showed plasmids were found to be resistant to
amoxicillin. On the other hand, no correlation was
observed between tetracycline resistance and plasmid
profiles. Most of the erythromycin-resistant isolates
showed prominent bands of plasmid DNA. However, no
inter-relation was found between the 2nd and 3rd
generation cephalosporin-resistance used (in this
investigation) and plasmid profiles. All the isolates were
found to exhibit resistance to penicillin G.
Although in the present study, it was observed that
there is a tendency that multi-drug resistant isolates
contain plasmids but no solid evidence could be
provided. In order to clarify this issue, further studies are
to be initiated. Abuse and irrational use of antibiotics will
lead to development of drug resistance. In a developing
country like Bangladesh, there is lack of guidelines in the
practice of antibiotic prescriptions. However, our studies
might provide a platform for physicians to choose and
prescribe rational antibiotics in the treatment of MRSA in
hospital and community infections.
ACKNOWLEDGEMENTS
The authors wish to thank Medinova Medical Services
Ltd. and the Popular Diagnostic Centre Ltd., Dhaka,
Bangladesh for supplying the clinical samples.
REFERENCES
Adeleke OE, Odelola HA (1997). Plasmid profiles of multiple drug
resistant local strains of Staphylococcus aureus. Afr. J. Med. Sci.,
26(3-4): 119-121.
118
J. Microbiol. Antimicrob.
Anupurba S, Sen MR, Nath G, Sharma BM, Gulati AK, Mohapatra TM
(2003). Prevalence of methicillin-resistant Staphylococcus aureus in
a tertiary referral hospital in eastern Uttar Pradesh. Indian J. Med.
Microbiol., 21: 49-51.
Bauer AW, Kirby WMM, Sherris JC, Turck M (1966). Antibiotic
susceptibility testing by a standardized single disk method. Am. J.
Clin. Path., 45: 493-496.
Boyce JM (1994). Methicillin-resistant Staphylococcus aureus : a
continuing infection control challenge. Eur. J. Clin. Microbiol. Infect.
Dis., 13: 45-49.
Brumfit W, Hamilton-Miller J (1989). Methicillin-resistant Staphylococcus
aureus. N. Eng. J. Med., 320: 1188-1196.
Chambers HF (2001). The changing epidemiology of Staphylococcus
aureus. Emerg. Infect. Dis., 7: 178-182.
Daini OA, Akano SA (2009). Plasmid-mediated antibiotic resistance in
Staphylococcus aureus from patients and non patients. Sci. Res.
Essay, 4(4): 346-350.
Diep BA, Chambers HF, Graber CJ, Szumewski JD, Miller LG, Han LL,
Chen JH, Lin F (2008). Emergence of multi-drug-resistant
community-associates Methicillin-resisitant Staphylococcus aureus.
Clone USA 300 in Men who have sex with men. Ann. Int. Med., 148:
1-17.
Diep BA, Gill SR, Chang RF, Plan TH, Chen JH, Davidson MG (2006).
Complete genuine sequence of USA 300, an epidemic clone of
community-acquired methicillin-resistant Staphylococcus aureus.
Lancet, 367: 731-739.
Foster T (1996). Staphylococcus, Barron's Medical Microbiology (Barron
S et al., eds.). 4th ed.; University of Texas Medical Branch.
Francis O, Harold LP, Roger FG, David G (1997). Antibiotic and
Chemotherapy. 7th ed., Churchill Livingston, U.K., p. 26.
Herwaldt LA, Wenzel RP (1996). Dynamics of hospital acquired
infections. In: manual of clinical microbiology. 6th ed. Washington
DC. Am. S. Microbiol., pp. 169-181.
Hotu B, Ellenbogen C, Hayden MK, Aroutcheva A, Rice TW, Weinstein
RA
(2007).
Community-associated
methicillin-resistant
Staphylococcus aureus skin and soft tissue infections at a public
hospital: do public housing and incarceration amplify transmission?
Arch. Int. Med., 167: 1026-1033.
Hsueh PR, Chen WH, Teng LJ, Luh KT (2005). Nosocomial infections
due to methicillin-resistant Staphylococcus aureus and vancomycinresistant enterococci at a university hospital from 1991 to 2003:
resistance trends, antibiotic usage and in vitro activities of newer
antimicrobial agents. Int. J. Antimicrob. Agents, 26: 43-49.
Khan MA, Mourshed MG, Khan WA, Aziz KMS (1991). The emergence
of methicillin resistant Staphylococcus aureus isolated from skin
lesion. Bangladesh J. Microbiol., 8(1): 21-25.
King MD, Humphrey BJ, Wang YF, Kourbalova EV, Ray SM, Blumbrg
HM (2006). Emergence of community-acquired methicillin-resistant
Staphylococcus aureus USA 300 clone as the predominant cause of
skin and soft tissue infections. Ann. Intern. Med., 144: 309-317.
Lyon BR, Skurray R (1987). Antimicrobial resistance of Staphylococcus
aureus: genetic basis. Microbiol. Rev., 5: 88-134.
Maltezou HC, Giamarellou H (2006). Community-acquired methicillin
resistant Staphylococcus aureus infections. Int. J. Antimicrob.
Agents, 27: 87-96.
Mansouri S, Khaleghi M (1997). Antibacterial resistance pattern and
frequency of Methicillin resistant Staphylococcus aureus . Irn. J. Med.
Sci., 22: 93-99.
Marples RR, Reith S (1996). Epidemic methicillin-resistant
Staphylococcus aureus. CDR Weekly, 6: 197.
Mehta AP, Rodrigue C, Seth K, Jani S, Hakiniyar A, Fazalbhoy N
(1998). Control of methicillin-resistant Staphylococcus aureus in a
tertiary care center: A five year study. Indian J. Med. Microbiol., 16:
31-14.
Mulligan ME, Murray-Leisure KA, Ribner BS, Standiford HC, John JF,
Korvick JA, Kauffman CA, Yu VL (1993). Methicillin resistant
Staphylococcus aureus: a consensus review of the microbiology,
pathogenesis and eptidemiology with implication for prevention and
management. Am. J. Med., 94: 313-328.
National Committee for Clinical Laboratory Standards (1997).
Performance standards for antimicrobial disk susceptibility tests.
Approved standard NCCLS Document M2-A6 (ISBN-56238-308-6).
6th ed..
O’Brien FG, Pearman JW, Gracey M, Riley TV, Grubb WB (1999).
Community Strain of Methicillin-resistant Staphylococcus aureus
involved in a hospital outbreak. J. Clin. Microbiol., 37: 2858-2862.
Okuma K, Iwakawa K, Turnidge J, Grubb WB, Bell JM, O'Brien FG,
Coombs GW, Pearman JW, Fred C, Tenover FC, Kapi M,
Tiensasitorn C, Ito T, Hiramatsu K (2002). Dissemination of new
methicillin-resistant Staphylococcus aureus clones in the community.
J. Clin. Microbiol., 40: 4289-4294.
Olukoya DK, Asielue JO, Olasupo NA, Ikea JK (1995). Plasmid profiles
and antibiotic susceptibility patterns of Staphylococcus aureus
isolates from Nigeria. Afr. J. Med. Sci., 24(2): 135-138.
Rahman M, Hossain M, Samad TMA, Shahriar M, Zakaria MM (2002).
Prevalence
of
β-lactamase
producing
methicillin-resistant
Staphylococcus aureus and antimicrobial sensitivity pattern.
Bangladesh Pharm. J., 12(2): 1-4.
Sampathukumar P (2007). Methicillin-Resistant Staphylococcus aureus:
The latest Health Scare. Moyo Clin. Proc., 82: 1403-1467.
Schito GC (2006). The importance of the development of antibiotic
resistance in Staphylococcus aureus. Clin. Microbiol. Infect., 12: 3-8.
Sieradzki K, Tomasz A (1997). Inhibition of cell wall turnover and
autolysis by vancomycin in a highly vancomycin-resistant mutant of
Staphylococcus aureus. J. Bacteriol., 179(8): 2557-2566.
Udaya SC, Harish BN, Umesh KPM, Navaneeth BV (1997). Prevalence
of methicillin resistant Staphylococcus aureus in JIPMER hospital.
Indian J. Med. Microbiol., 15: 137-138.
Udo EE, Pearman JW, Grubb WB (1993). Genetic analysis of
community isolates of methicillin-resistant Staphylococcus aureus in
Western Australia. J. Hosp. Infect., 25: 97-108.
Vidhani S, Mehndiratta PL, Mathur MD (2001). Study of MRSA isolates
from high risk patients. Indian J. Med. Microbiol., 19: 87-90.